[HTML][HTML] Passive immunotherapy against SARS-CoV-2: from plasma-based therapy to single potent antibodies in the race to stay ahead of the variants

WR Strohl, Z Ku, Z An, SF Carroll, BA Keyt, LM Strohl - BioDrugs, 2022 - Springer
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

[PDF][PDF] Passive Immunotherapy Against SARS‑CoV‑2: From Plasma‑Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

WR Strohl, Z Ku, Z An, SF Carroll, BA Keyt, LM Strohl - 2022 - researchgate.net
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

Passive Immunotherapy Against SARS-CoV-2: From Plasma‑Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

WR Strohl, Z Ku, Z An, SF Carroll, BA Keyt… - …, 2022 - search.proquest.com
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

WR Strohl, Z Ku, Z An, SF Carroll… - … and gene therapy, 2022 - pubmed.ncbi.nlm.nih.gov
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

[PDF][PDF] Passive Immunotherapy Against SARS‑CoV‑2: From Plasma‑Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

WR Strohl, Z Ku, Z An, SF Carroll, BA Keyt, LM Strohl - 2022 - scienceopen.com
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

[HTML][HTML] Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

WR Strohl, Z Ku, Z An, SF Carroll, BA Keyt, LM Strohl - Biodrugs, 2022 - ncbi.nlm.nih.gov
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

WR Strohl, Z Ku, Z An, SF Carroll, BA Keyt… - … and Gene Therapy, 2022 - europepmc.org
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

Passive immunotherapy against SARS-CoV-2: from plasma-based therapy to single potent antibodies in the race to stay ahead of the variants.

WR Strohl, Z Ku, Z An, SF Carroll, BA Keyt, LM Strohl - 2022 - cabidigitallibrary.org
The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …